API Product

Mometasone Furoate Monohydrate

mometasone-furoate-monohydrate
Product Status:
Commercial
Available Grades:
  • Inhalation
Regulatory Status:
ASMF
US DMF
Production Sites:
  • Hovione Loures
Product Type:
  • Corticosteroids
CAS Number:
141646-00-6
Modes of Application:
  • Nasal
Common Indications:
  • Allergic rhinitis
  • Asthma
Last Inspection:
FDA May 2018

Hovione can customize Mometasone Monohydrate API for nasal suspensions or inhalation based on its experience in particle size reduction technologies with tailored made, highly reproducible particle size distributions.

High crystaline purity, low amorphous content with prolonged stability are also part of our offering.

Hovione Mometasone Monohydrate API is available since 2008 and is approved in generic applications.

 

 

 


This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (84.51 KB)
Download